According to the International Classification of Headache Disorders (ICHD-3 beta), a chronic migraine is defined as experiencing headaches on at least 15 days per month, with at least 8 of those days meeting the criteria for migraines
Combination-specific volume arithmetic is handled separately on the cagrilintide/semaglutide 10 mg blend protocol, and the metabolic rationale is explored in our cagrilintide prediabetes research overview
That means looking beyond BMI to assess inflammation, insulin resistance, family history, and lifestyle
NICE recommends sleep hygiene measures and Cognitive Behavioural Therapy for Insomnia (CBT-I) as first-line treatments
Whether youre using Wegovy, compounded injectables, or another GLP-1 formulation, the focus shifts from increasing to sustaining. Your provider may reassess your dose every 8 to 12 weeks depending on progress